How the EU Is Tackling Medicine Shortages: NSF Pharma Biotech Conference 2024

Generative AI in Life Sciences: How NSF Is Reimagining Trials, Devices & GXP

AI in the Micro Lab: How AstraZeneca Uses Automated Colony Counting in Aseptic Manufacturing

AI in Pharma: Michael Hidock Explains the Real Future of Automation, R&D, and FDA Expectations

AI, Drug Shortages & Global Regulation: Dr. Peter Gough’s 2024 Update

Why Medicine Shortages Are Rising: Paul Fleming on Generics, Brexit and Supply Resilience

The Future of Quality Management Systems: Are You Ready for What’s Coming?

Innovation with Purpose: Alan Moon on Annex 1, Risk, and Patient Protection

NSF Pharma Biotech Conference 2023 - Paul O'Connor, Almac

NSF Pharma Biotech Conference 2023 - Rachel Carmichael

Quality Culture, QMM & the Future of Pharma

NSF Pharma Biotech Conference 2025 -Newaj Khan

AI in Pharma: Enabler or Risk? Inside the NSF Panel on Trust, Quality & Compliance

NSF Pharma Biotech Conference 2025 - Niamh Bissett

Contamination Control, Quality Culture, and Workforce: 2025 NSF Pharma Biotech Conference Q&A

NSF Pharma Biotech Conference 2025 - Adam Walker and Marc Sutton

Compliance vs. Quality Culture: What the Opinium Report Reveals About Pharma in 2026

NSF Pharma Biotech Conference 2025. Dr. Peter Gough - AI & Decentralised Manufacturing

Europe’s Pharma Quality Benchmark 2025: The Insights Every Leader Must Know

How Strong Leadership Transforms Regulatory and Operational Challenges

What’s Changing at the FDA? Dr. Julia Marré Explains the New U.S. Regulatory Landscape

AI in Pharma: Practical Use Cases Transforming Research, Regulatory and Medical Affairs

NSF/ANSI 305: The State of Conscious Beauty

NSF/ANSI 305 Personal Care Products Containing Organic Ingredients: A Technical Review 091825

NSF Webinar on the Life Science Sector in Ireland: Promo

Navigating Strengthening Organic Enforcement (SOE) Compliance Part 1

Navigating Strengthening Organic Enforcement (SOE) Compliance Part 2

NSF QP Training – Expert Tutoring and Personalized Mentoring

Redefining QP Training

Pathways to Becoming A Qualified Person (QP)

The Requirements to Become a QP (Qualified Person)

NSF Celebrates 35 Years of Qualified Person (QP) Training

The Future of QP Training: Skills, Talent, and Career Pathways

Compliance Unlocked Episode 2: Building A Quality Culture, and more

Inside the QP Role: Risk, Pressure, and Leading Quality in Pharma

How to Survive—and Succeed—During Pharma Regulatory Inspections

FDA Inspection Readiness Explained: What Regulators Really Want to See

NSF's Pete Gough: 50 Years in the Pharma Industry

S2E1 | Proof in the Product: Validating PFAS-Free Claims

S1E6 | Sustainability in action: Where are we now?

S1E5 | Balancing food safety with sustainability

S1E4 | Getting ahead of regulatory change

S1E3 | Sustainability in a changing world

S1E2 | Chemicals of concern in the grocery supply chain

S1E1 | Eco fatigue and the cost of living

NSF Celebrates 80 Years of Improving Human and Planet Health

How to Prepare for Regulatory Inspections conducted by FDA, EMA, MHRA, and PIC/S

Webinar: Understanding the Regulatory Landscape of Drug-Device Combination Products in the EU

Webinar: What You Need To Know About Annex One

Webinar: FDA Inspection Readiness - How To Prepare

Regulatory Inspections: What Is An Inspector Looking For?

Regulatory Inspections: Why The Opening Meeting Matters

Regulatory Inspections: The Importance of the Closing Meeting

Regulatory Inspections: The Power of a Strong Opening Meeting

Regulatory Inspections: Building Trust with an Inspector

Regulatory Inspections: Common Pitfalls and How To Avoid Them

Webinar: 5 Ways To Ensure Successful Internal Audits

Webinar: Ireland - How The Irish Life Sciences Sector is Leading the World

Webinar: Why is Quality Culture Critical to Manufacturing Success?

Essential Regulatory Inspection Survival Guide: Expert Advice from NSF